ASEA Sues Pfizer Over its Neurontin Off-Label Marketing Scheme
Monday, June 7th, 2004Source: BI Daily News
Alaska State Employees Association Health Benefit Trust filed a lawsuit against Pfizer Inc. and its subsidiary Warner-Lambert Co. over its off-label marketing scheme of its top selling epilepsy drug Neurontin.
The lawsuit, filed last week in U.S. District Court in Newark, N.J., contends that Pfizer made billions of dollars of fraudulent revenues by promoting Neurontin as a treatment for a variety of disorders not approved by the U.S. Food and Drug Administration.
Pfizer, the world’s largest pharmaceutical company, plead guilty in May and agreed to pay more than $430 million to settle all criminal charges and civil liabilities related to the illegal and fraudulent promotion of unapproved uses for Neurontin, the Justice Department said in a statement.
The ASEA lawsuit seeks damages on behalf of health plans and others that have paid for Neurontin for so-called “off-label” uses since Jan. 1, 1994
PR Consultant | Write and Send Press Release
PR consultant provides affordable public relations, press release writing and distribution, talk radio and TV interview booking, press kits, and web site content writing.
